Funding Received
$4 Million in 4 Rounds from 1 Investor
Most Recent Funding
$2 Million Series A on February 21, 2014
Founded:
2009
Headquarters:
Ísafjörður
Description:
Kerecis is a developer of patent-pending MariGen™, an omega3 fish-skin acellular dermal matrix transplantation technology.
Founders:
Baldur Tumi Baldursson, Gudmundur F. Sigurjonsson, J. Ernest Kenney, Hilmar Kjartansson (M.D.)
Categories:
Medical Devices
Website:
http://www.kerecis.com

Detailed Description

Update

Kerecis is developing the MariGen™ Omega3 acellular dermal matrix technology for use in products to treat chronic wounds, for hernia repair, breast reconstruction and abdominal wall reconstruction. Our patent pending acellular fish skin derived material improves upon current human and porcine technologies through improved economics and clinical performance, reduced disease transfer risk and absence of cultural constraints on usage.

Current Team (6)

Update

Past Team (1)

Update

Funding Rounds (4) - $4M

Update

Investors (1)

Update

Offices/Locations (2)

Update
  • Headquarters

    Eyrargata 2

    Ísafjörður, 400

    ISL

  • Reykjavik, Iceland Office

    Skolavordustigur 16

    Reykjavík, 101

Competitors (1)

Update

Images (1)

Update
  • C2e3ppacyalcb83uitlq